Treprostinil Sodium Inhalation for Patients At High Risk for ARDS

NCT02370095 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Respiratory Distress Syndrome, Adult

Interventions

DRUG: Treprostinil Inhalation Solution
DRUG: Placebo

Sponsor

University of North Carolina, Chapel Hill

Collaborators

[object Object]